Evaluating the Genomic Composition of AAV Vectors & It’s Impact on Gene Therapies

Time: 2:45 pm
day: Day One


This presentation aims to answer key questions such as:

  • What are the key DNA configurations of AAV vectors?
  • What are the biological effects of AAV contaminants?
  •  How to make vectors free of such contaminants?